My 94-Year-Old Father Dropped A Bomb During A Zoom Call. The Explosion Changed Everything.
I seldom heard from my father. We had never been close, but when he was 94 years old, he left me a brief voice message.
'I have something important to tell you — something very personal and private,' he said.
A feeling of dread swept over me.
Was he ill? Had I done something wrong? We never shared anything that was 'personal and private.' Even his suggestion to meet by Zoom surprised me. When did my father start using Zoom?
I agreed to talk to him, and when I signed into Zoom, he was already there waiting for me. He appeared nervous and had difficulty directly looking at me. It took him a moment to get started.
'When I was a medical student, I worked at a pioneering fertility clinic,' he said. 'On several occasions, I donated sperm. A year ago, I was contacted by a woman who thought I might be her father.'
He took my stunned silence as an invitation to go on.
'I know this is a shock, but it appears that I fathered over a dozen children through sperm donation.'
'Oh my God,' I barely managed to reply.
'Yes, they had been searching for me — well, not for me at that point, but for their father,' he said. 'They found each other on one of the DNA websites, shared their stories, did some research, and narrowed it down to me.'
My father was a highly renowned OBGYN and researcher. He was a brilliant man, capable of great charm and humor, who, even at the age of 94, remained astute and worldly. His children were thrilled to have discovered him, and he soon found himself the object of fascination of these newly acquainted offspring.
My father reveled in these relationships, basking in the loving light they cast. He held Zoom meetings with them, corresponded with some over email, and met others in person.
I learned this had been going on for almost a year before he had his Zoom call with me, and that he had become particularly close to one of my new half-sisters. She adored my father. He told me that she said she had never experienced such a quick bond with another human being. They described each other as 'soulmates.' They even had loving nicknames for each other — he called her 'Dollie' and she called him 'Poppie.'
This was hard for me to take in. The father I knew was full of rage and violent. Taunting, threatening, blaming and shaming were the currency he used with our family. His nicknames for me during my childhood were 'bitch,' 'birdbrain,' and 'moron.' As the family scapegoat, I was beaten. I thought I was so 'bad' that I didn't believe I was worthy of having weight on this earth. I was anorexic for much of my adolescence, and when I was a freshman in college, I tried to kill myself.
My healing journey included years of therapy and recovery. Though my relationship with my father was complicated and tenuous, I loved my father. Despite the way he often treated me, he had always been supportive of my passion for creating art. Even in his 90s, he continued to help me with my website. He could still be unpredictably demeaning and cruel, however, and our interactions were stiff and formal.
I could understand why he had waited to tell me. These new relationships presented him with the chance to have a do-over — an opportunity to reset his self-image as a father. I'm sure he feared that I might say or do something to pollute my half-siblings' high regard for him.
It's hard to explain. But though I felt hurt about being kept in the dark, I also felt glad for my father — that this final chapter of his life brought him some joy — and I felt a flutter of excitement for myself. I had miraculously inherited a whole new family of brothers and sisters. We did not share a history of growing up with this complex man, but we shared something profound, ancient, mysterious, and awe-inspiring: a DNA passed down through generations.
I was genuinely intrigued. I wanted to meet them. Also, despite the years of hurt, fear and estrangement I suffered, I also wanted a closer relationship with my father. The fork in the road was stark and clear: I could travel with him in his pursuit of these new relationships or I could watch him fade away from my life.
My father was apprehensive about me reaching out to my new siblings, but he provided me with their contact information. I began emailing them and eventually spoke to many of them by phone. They invited me to join an upcoming Zoom call with my father, where they intended to ask him more about himself.
The meeting was visually stunning: all of these strangers bore a resemblance to my father, and I saw variations of my sister's and brother's faces filling the screen. One of my half-sisters was a mirror image of me! It was both fascinating and exciting, yet also awkward and lonely. All of these people shared a common awakening to their new reality. I was connected to everyone, too, of course, but it was also very different for me, and none of us knew quite how I fit into the group.
Over the next several days, a few more siblings I hadn't talked to reached out to me, including the half-sister that my father referred to as 'Dollie.' She seemed to want to get to know me. I was pleased, but part of me also wanted to run away while screaming my renunciation of my father and these starry-eyed half-siblings. Still, I had resolved early on that I would not do anything to try to sabotage the new relationships, and I was determined to keep my promise.
Over time, Dollie and I reached a point of mutual understanding. I had the courage to hear more about her and her love for my father, and she dared to ask me about my history with him. We had some difficult conversations, and there were times we had to help each other through the hurt.
I learned that, like me, she was in recovery and attended a 12-step program. Her love for him and their open discussions about her recovery resonated deeply with him. In one of our conversations, he sheepishly disclosed that he had begun attending a 12-step program with her.
My parents had always denigrated my involvement in self-help and therapy, and I had learned to keep my recovery hidden so as not to face their disdain. Now he was speaking my language! He talked with me about believing in a higher power and beginning to work the 12 steps of recovery, which included taking an honest self-inventory and making amends. Rather than a wedge between us, itbecame a foothold for a spiritual place of healing and union. We could actually talk with each other.
Dollie also began telling my father how close she and I were becoming and that we supported him in his relationships with both of us. Hearing this profoundly touched him. His anxiety about how my presence might undermine his new relationships seemed to disappear.
This progress was amazing, but there was more. My father wrote me a letter stating that he wished he had been 'a different kind of dad, more outwardly caring and loving.' He said that facing his deficiencies as a parent was 'like looking into the abyss.' He wanted to make amends for his 'shortcomings and the hurt I had caused you.' I called him to thank him, tell him I loved him, and let him know that we could embark on a healing journey together. My half-sister's love for him, untainted by the past, coupled with my openness to his overture of amends, was a lifeline for him.
Despite how far the three of us had come together, we were still apprehensive about meeting in person. What would happen? We weren't sure, but we agreed it was time to find out.
We agreed to meet at my half-sister's house, which was located just outside the city where my father lived, and a seven-hour drive from my home. It would be Dollie and her partner, my husband and me... and my father.
It was a most remarkable visit.
Yes, it was awkward at times, but there was also a feeling of togetherness — that we were all trying our best to do something hard but important. At one point, the five of us were sitting at the dinner table when my father said he had something he needed to express. Then he turned and looked directly at me.
'I want to apologize to you for my over 60 years of abusive behavior toward you,' he said.
He told me that he saw me, was proud of me, and loved me very much. He turned to Dollie and said that he loved her too. Tears streamed down my face. I could barely speak.
There's a photo of the five of us from that weekend, and it looks like a photo of a family, which is exactly what we'd become.
Of course, it's nearly impossible to heal from a lifetime of hurt in just a few years, and not all of my mistrust had simply evaporated. My father is now 98. We have a long way to go and a short amount of time, but we are both invested in each other and moving forward. We begin and end each phone call with 'I love you,' and that feels like the most important thing.
This story could have ended so differently. Though I was still trying, my connection with my father had been degraded to the point that I had little expectation or hope for a reconciliation. My father and I had become accustomed to the coldness. I thought there would be nothing more for us to learn or gain. The sudden arrival of — and his quick attachment to — 16 new, charming, loving adult children felt like one more mortal threat to my years-long efforts to find a loving place with him.
The miracle is that we all played our parts and dared to stay open to one another. I will always be grateful for that.
Dollie and I continue to call each other. We update each other about our lives. We reflect on our remarkable journey. And we talk about our father.
My father passed away as this article was being edited. As his condition worsened and he could barely speak, he would open his eyes and tell me that he loved me. In the days before his death, I was in touch with everyone to let them know he didn't have much time left.
His loving family — including my brother, two of my new half-sisters and two of my new half-brothers — gathered at his bedside. What good fortune it is that I have so many more people in my life to love and with whom to share my sorrow.
My grief has been complicated. I never expected to cry as much as I have. I'm surprised at my utter desolation. I wish I had had more time with my 'new' father. I forgive him — this flawed man whom I love — but what I hope for most is that he was able to forgive and love himself.
Meryl Ruth has gained international recognition for achievement of high-quality, intricately detailed and imaginative ceramic and fiber art. Her work is on display on her website www.merylruth.com. Meryl lives with her husband on a small lake in Maine, where she also has her art studio. She and her husband are currently collaborating on her memoir, from which this essay is drawn. When Meryl is not working in her studio, she is spending time with her children and grandchildren, practicing yoga, kayaking on the lake and cultivating orchids. She has a small Chihuahua, who is a certified therapy dog and accompanies her to hospice where she has volunteered on a weekly basis for the past ten years. She would like to acknowledge her husband, Fred Wolff, 'for helping me put my thoughts and feelings into words.'
Do you have a compelling personal story you'd like to see published on HuffPost? Find out what we're looking for here and send us a pitch at pitch@huffpost.com.
My Husband And I Assumed We Would Have Kids. Then Something Incredible Happened That Changed Our Minds.
My Patient Invited Me To Her Home To Watch Her Die. What I Saw When I Arrived Gave Me Goosebumps.
People See Me And Think I'm Pregnant. They're Shocked When I Tell Them The Heartbreaking Truth.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
29 minutes ago
- Medscape
ASCO 2025: New Standards Reshape Care in mBC
Heather McArthur, MD, describes how the 2025 ASCO Annual Meeting brought exciting advances in the metastatic breast cancer space. In PD-L1-positive triple-negative breast cancer, sacituzumab govitecan combined with pembrolizumab significantly improved progression-free survival over standard chemotherapy plus pembrolizumab, quickly becoming a new standard of care. Similarly, in HER2-positive disease, trastuzumab deruxtecan combined with pertuzumab outperformed traditional THP therapy, offering a new frontline option. Overall, these findings signify a major shift in how to treat metastatic breast cancer.


Health Line
29 minutes ago
- Health Line
Stages of Crohn's Disease
Key takeaways Crohn's disease symptoms can be mild, moderate, or severe. It's a progressive disease, but its stages are hard to determine because each person's condition progresses differently. The earlier you treat and manage Crohn's, the more likely you are to reduce your chance of developing more severe symptoms. There's no cure for Crohn's disease, but medications and lifestyle changes can help manage the condition. This is why it's crucial to identify the disease when symptoms are still mild. Crohn's disease is a type of inflammatory bowel disease (IBD). It's considered a chronic condition, which means that you'll have it for your entire life. The exact cause of Crohn's is unknown. It most often develops in your late teens or 20s. Crohn's disease is marked by inflammation of the gastrointestinal (GI) tract. The inflammation can appear anywhere in the GI tract, from the mouth to the anus. What are the stages of Crohn's disease? Crohn's is a progressive disease that starts with mild symptoms and gradually gets worse. With mild to moderate Crohn's, you may experience diarrhea or abdominal pain, but you won't experience other symptoms or complications. You're able to move, eat, and drink as normal, and the disease has a minimal impact on your quality of life. In some cases, you won't even require treatment. If you have moderate to severe Crohn's disease, you may experience diarrhea or abdominal pain, as well as additional symptoms and complications, such as fever or anemia. If your Crohn's is severe, you might be in constant pain and discomfort, and you may need to use the bathroom frequently. That said, it's difficult to classify Crohn's disease into stages because people tend to experience ups and downs in symptoms. What progression looks like can be different for each person, and treatment can affect your outlook. How quickly does Crohn's disease progress? Over time, Crohn's can cause damage to the intestines and lead to potential complications such as strictures, fistulas, and abscesses. Stricture means that a portion of the intestine becomes narrower due to scar tissue on its wall. While there's no time frame for how long it would take for such complications to develop, there are risk factors that may speed up progression. These include: being under 30 years old having a history of smoking having ulcers found in a colonoscopy having the long bowel segments affected by the disease having anal inflammation having symptoms that go beyond the intestinal system, such as in the eyes, skin, liver, or joints having a history of bowel resections At diagnosis, 10% of people already have strictures, and an additional 15% to 20% will develop them within the next 10 to 20 years. Five types of Crohn's disease Progression may also depend on the type of Crohn's disease you have. These are: ileocolitis ileitis gastroduodenal Crohn's disease diffuse jejunoileitis Crohn's colitis Crohn's disease progression patterns The patterns by which Crohn's might progress are: Chronic relapsing: With this progression type, you typically experience at least 12 months of remission before experiencing a flare. Common symptoms of a Crohn's disease flare-up may include diarrhea, abdominal pain, weight loss, blood in stool, and fatigue. Remission: Remission means that your symptoms improve or disappear completely. Various studies show most people will relapse within 8 years of diagnosis, with a 43% to 45% remission rate after 10 years. But if you stay in remission for a year, there's an 80% chance remission will continue for the next year. Improved and stable: This is when your condition has progressed to having no symptoms and has remained this way, though signs of the disease might still show up on tests. Chronic refractory: This means you continue to show symptoms without any breaks or remission. About 10% to 15% of people with Crohn's experience a chronic refractory disease course. That said, even different people living with the same Crohn's pattern might progress differently. Genetics, type of treatment, and surgery are also factors that may affect which disease course you follow. The earlier you treat and manage Crohn's, the more likely you are to reduce your chance of developing more severe symptoms. What is the life expectancy of someone with Crohn's disease? There's no cure for Crohn's disease, though many people can live fulfilling lives with long periods of remission. That said, although there's been an increase in life expectancy for people living with inflammatory bowel diseases (IBDs), the life expectancy of Crohn's is still lower compared to those without IBDs for both males and females. When Crohn's causes complications, it can, in rare cases, lead to death. Common causes of death include cancer, heart disease, and infection. What are the early symptoms of Crohn's disease? In Crohn's disease, healthy cells in the GI tract attack themselves, causing inflammation. As a result, you'll likely experience a range of symptoms. Early signs of Crohn's disease include: frequent cramps ongoing abdominal pain frequent diarrhea bloody stools unintentional weight loss As the disease progresses, you may start feeling fatigued and even develop anemia. You may also experience nausea from constant irritation of the GI tract. In addition, you may start experiencing symptoms outside of the GI tract. These symptoms include: eye pain fever joint inflammation and pain red skin rashes and bumps mouth sores Early diagnosis is important to help prevent damage to the intestines. If you experience these symptoms and have a family history of Crohn's, you should ask your doctor for testing. How is Crohn's disease treated and managed? Medications can treat inflammation and stop your body from attacking its own cells. As your symptoms progress, your gastroenterologist may also recommend occasional bowel rest. However, not all doctors agree with this measure. A bowel rest involves a strict diet of only liquids for a few days. The purpose is to let the GI tract heal from inflammation and essentially take a break. To prevent malnutrition, you may need an IV. Talk with your doctor before switching to a liquid diet. Following this, your doctor may follow a special Crohn's diet and take supplements. You also may need to take pain medication. Avoid nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil, Motrin), as these can make Crohn's worse. Instead, ask your doctor if you can safely take acetaminophen (Tylenol). You may need surgery if your symptoms become life threatening. Around 67% to 75% of all people with Crohn's will eventually need surgery, according to the Crohn's & Colitis Foundation. Surgery can't cure the disease, but it may help repair severely damaged tissues and remove blockages.


Health Line
29 minutes ago
- Health Line
Current and Breakthrough Treatments for Chronic Lymphocytic Leukemia (CLL)
Key takeaways Chronic lymphocytic leukemia (CLL) is a slow-growing cancer of the immune system. Because it's slow growing, many people with CLL won't need to start treatment for many years after their diagnosis. Once the cancer begins to grow, many treatment options are available that can help people go into remission. This means people can experience long periods of time when there's no sign of cancer in their bodies. While there's no cure for CLL yet, breakthroughs in the field are on the horizon. A large number of approaches are under investigation to treat CLL, including drug combinations and CAR T-cell therapy. Chronic lymphocytic leukemia (CLL) is a slow-growing cancer of the immune system. Because it's slow-growing, many people with CLL won't need to start treatment for many years after their diagnosis. Once the cancer begins to grow, there are many available treatment options that can help people achieve remission. This means people can experience long periods of time when there's no sign of cancer in their bodies. The exact treatment option that you'll receive depends on a variety of factors. This includes: whether your CLL is symptomatic the stage of the CLL, based on results of blood tests and a physical exam your age your overall health While there's no cure for CLL yet, breakthroughs in the field are on the horizon. Treatments for low risk CLL Doctors typically stage CLL using a system called the Rai system. Low risk CLL describes people who fall in 'stage 0' under the Rai system. In stage 0, the lymph nodes, spleen, and liver are not enlarged. Red blood cell and platelet counts are also near normal. If you have low risk CLL, your doctor (usually a hematologist or oncologist) will likely advise you to ' watch and wait ' for symptoms. This approach is also called active surveillance. Someone with low risk CLL may not need further treatment for many years. Some people will never need treatment. You'll still need to see a doctor for regular checkups and lab tests. Treatments for intermediate or high risk CLL Intermediate risk CLL describes people with stage 1 to stage 2 CLL, according to the Rai system. People with stage 1 or 2 CLL have enlarged lymph nodes and potentially an enlarged spleen and liver but close to normal red blood cell and platelet counts. High risk CLL describes patients with stage 3 or stage 4 cancer. This means you may have an enlarged spleen, liver, or lymph nodes. Low red blood cell counts are also common. In the highest stage, platelet counts may be low as well. If you have intermediate or high risk CLL, your doctor will likely recommend that you start treatment right away. Chemotherapy and immunotherapy In the past, the standard treatment for CLL included a combination of chemotherapy and immunotherapy agents, such as: a combination of fludarabine and cyclophosphamide (FC) FC plus an antibody immunotherapy known as rituximab (Rituxan) for people younger than 65 bendamustine (Treanda) plus rituximab for people older than 65 chemotherapy in combination with other immunotherapies, such as alemtuzumab (Campath), obinutuzumab (Gazyva), and ofatumumab (Arzerra). These options may be used if the first round of treatment doesn't work. Targeted therapies Over the last few years, a better understanding of the biology of CLL has led to a number of more targeted therapies. These drugs are called targeted therapies because they're directed at specific proteins that help CLL cells grow. Examples of targeted drugs for CLL include: zanubrutinib (Brukinsa): Approved by the Food and Drug Administration (FDA) in 2023, zanubrutinib targets the enzyme known as Bruton's tyrosine kinase (BTK), which is crucial for CLL cell survival. ibrutinib (Imbruvica): This targets BTK with less precision than zanubrutinib. venetoclax (Venclexta): This used in combination with obinutuzumab (Gazyva), targets the BCL2 protein, a protein seen in CLL. idelalisib (Zydelig): This blocks the kinase protein known as PI3K and is used for relapsed CLL. duvelisib (Copiktra): This also targets PI3K but is typically used only after other treatments fail. acalabrutinib (Calquence): This is another BTK inhibitor approved in late 2019 for treating CLL. Monoclonal antibody therapies Monoclonal antibody therapies are a type of treatment in which proteins are made in a laboratory and designed to target certain antigens. They help jolt your immune system into attacking the cancer cells. There are several monoclonal antibody treatments approved for treating CLL by targeting the antigens CD20 and CD52: rituximab (Rituxan): targets CD20, often used with chemotherapy or targeted therapy as part of the initial treatment or in the second-line treatment obinutuzumab (Gazyva): targets CD20, used with venetoclax (Venclexta) or chlorambucil (Leukeran) for patients with previously untreated CLL ofatumumab (Arzerra): targets CD20, usually used in patients whose disease has not responded to prior treatments and is given in combination with chlorambucil (Leukeran) or FC alemtuzumab (Campath): targets CD52 Blood transfusions You may need to receive intravenous (IV) blood transfusions to increase blood cell counts. Radiation Radiation therapy uses high-energy particles or waves to help kill cancer cells and shrink painful, enlarged lymph nodes. Radiation therapy is rarely used in CLL treatment. Stem cell and bone marrow transplants Your doctor may recommend a stem cell transplant if your cancer doesn't respond to other treatments. A stem cell transplant allows you to receive higher doses of chemotherapy to kill more cancer cells. Higher doses of chemotherapy can cause damage to your bone marrow. To replace these cells, you'll need to receive additional stem cells or bone marrow from a healthy donor. Breakthrough treatments A large number of approaches are under investigation to treat people with CLL. Some have been recently approved by the FDA. Drug combinations In May 2019, the FDA approved venetoclax (Venclexta) in combination with obinutuzumab (Gazyva) to treat people with previously untreated CLL as a chemotherapy-free option. In April 2020, the FDA approved a combination therapy of rituximab (Rituxan) and ibrutinib (Imbruvica) for adult patients with chronic CLL. These combinations make it more likely that people may be able to do without chemotherapy altogether in the future. Nonchemotherapy treatment regimens are essential for those who can't tolerate harsh chemotherapy-related side effects. CAR T-cell therapy One of the most promising future treatment options for CLL is CAR T-cell therapy. CAR T-cell therapy, which stands for chimeric antigen receptor T-cell therapy, uses a person's own immune system cells to fight cancer. The procedure involves extracting and altering a person's immune cells to better recognize and destroy cancer cells. The cells are then put back into the body to multiply and fight off the cancer. CAR T-cell therapy research is still ongoing. In September 2023, researchers reported a possible 'universal' CAR T-cell treatment that may be effective in all types of blood cancers. CAR T-cell therapies are promising, but they do carry risks. One risk is a condition called cytokine release syndrome. This is an inflammatory response caused by the infused CAR T-cells. Some people can experience severe reactions that may lead to death if not quickly treated. Other drugs under investigation Some other targeted drugs currently being evaluated in clinical trials for CLL include: entospletinib (GS-9973) tirabrutinib (ONO-4059 or GS-4059) cirmtuzumab (UC-961) ublituximab (TG-1101) pembrolizumab (Keytruda) nivolumab (Opdivo) Once clinical trials are completed, some of these drugs may be approved for treating CLL. Talk with a doctor about joining a clinical trial, especially if current treatment options aren't working for you. Clinical trials evaluate the efficacy of new drugs as well as combinations of already approved drugs. These new treatments may work better for you than the ones currently available. Hundreds of clinical trials are ongoing for CLL.